Jigar Mistry of Buoyant Capital favors healthcare, materials, chemicals, and banking sectors, preferring large-cap private banks over PSU banks. He remains positive on both generic and CDMO pharma segments, dismissing tariff concerns. Mistry believes valuations are elevated, especially for narrative-driven stocks lacking earnings, advocating for a focus on fundamentals over market flows.
Saksoft shares rally 50% in one week. Here’s what technical charts indicate
Saksoft shares experienced a significant surge, climbing over 14% on Tuesday and an impressive 50% in a single week. This rally follows a decisive technical
June 30, 2026